CCM
Concord Medical Services Holdings Limited
There isn't enough reported data to score CCM yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
CCM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Weak |
CCM's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CCM PE Valuation
CCM has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
CCM Forward outlook
There aren't enough analyst estimates for CCM to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.11 | +$0.24 |
| Q4 2024 | -$0.35 | +$3.06 |
| Q4 2023 | -$3.41 | +$2.20 |
| Q4 2020 | -$7.67 | -$1.31 |
| Q4 2019 | -$6.36 | -$2.22 |
| Q4 2018 | -$4.14 | -$0.85 |
| Q4 2017 | -$3.29 | -$0.29 |
| Q4 2016 | -$3.00 | -$2.13 |
CCM is still losing money, but far less than before: $0.11 per share over the past year, against $7.67 at its worst in late 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over CCM in the latest year-over-year earnings comparison.
CCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $69.1M | +20% |
| Q4 2024 | $57.6M | -29% |
| Q4 2023 | $80.6M | +14% |
| Q4 2022 | $70.8M | -2.8% |
| Q4 2021 | $72.9M | +118% |
| Q4 2020 | $33.5M | +12% |
| Q4 2019 | $29.8M | +3.9% |
| Q4 2018 | $28.6M | -42% |
CCM's revenue is growing: $69M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -57% | +38 points |
| Q4 2024 | -139% | +3.1 points |
| Q4 2023 | -86% | +134 points |
| Q4 2022 | -111% | +46 points |
| Q4 2021 | -94% | -30 points |
| Q4 2020 | -142% | -105 points |
| Q4 2019 | -220% | -220 points |
| Q4 2018 | -157% | -187 points |
CCM's operating margin was −57% last quarter, up 38 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over CCM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
CCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$38.7M | +$43.6M |
| Q4 2024 | -$82.3M | -$23.9M |
| Q4 2023 | -$58.4M | +$7.5M |
| Q4 2022 | -$66M | +$29.8M |
| Q4 2021 | -$95.8M | -$36.1M |
| Q4 2020 | -$59.7M | +$4.5M |
| Q4 2019 | -$64.2M | -$33.6M |
| Q4 2018 | -$30.6M | -$21M |
CCM has burned cash in most quarters: −$245M over the past year, against −$250M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
CCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2015 | 4.7x | High |
| Q4 2014 | 1.1x | Healthy |
| Q4 2013 | 2.2x | Moderate |
| Q4 2012 | 2.3x | Moderate |
CCM's net debt is about 4.7 years of its operating earnings (EBITDA).
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 28.6 | Neutral |
CCM's weekly RSI is 44 (neutral) and its Stochastic is 29 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CCM PE vs Healthcare Sector
CCM has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.65 | 2.7% below |
| 20 week MA | $4.17 | 15% below |
| 50 week MA | $4.24 | 16% below |
| 100 week MA | $4.79 | 26% below |
| 200 week MA | $7.27 | 51% below |
CCM is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CCM on trend strength, trading above more of its moving averages.
CCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $29.1 | +6.6% |
| 2021 | $29.1 | $20.5 | -30% |
| 2022 | $20.5 | $16.6 | -19% |
| 2023 | $16.6 | $11.0 | -34% |
| 2024 | $11.0 | $5.02 | -54% |
| 2025 | $5.02 | $3.76 | -25% |
| 2026 YTD | $3.76 | $3.55 | -5.6% |
CCM has finished five years in a row lower, and it's down 5.6% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over CCM on returns for 2026, with the stronger performance.